Compounded medication preparations are integral to all hospital pharmacies, regardless of whether those products are made within the pharmacy or are compounded by a third party. In both cases, the desired outcome is the same: the production of safe, effective, and appropriate therapies. The prevailing document affecting the governance of creating compounded sterile preparations, USP General Chapter <797>, is now joined by the latest issuance from the USP, General Chapter <800>, which will go into effect July 1, 2018. That provides a little over a year to gain compliance.
With this in mind, now is the time to make a concerted push to adopt the guidelines set forth in USP <800>, and certainly USP <797>, and as you will see in the pages that follow, there are many areas in which pharmacy compounding practices can improve. In particular, many hospital pharmacies will require upgrades to their compounding facilities to comply with <800>; in fact, most facilities with older cleanrooms are currently planning to renovate their compounding cleanrooms over the next several months. With this strong activity projected in pharmacy renovation, proper planning and detailed action plans will be key to success. Pharmacy Purchasing & Products is committed to providing you with resources, guidance, and the support you need to achieve your goals.
To this end, PP&P provides the data in our State of Pharmacy Compounding issue as a PowerPoint slide package. For a decade now, pharmacy directors and managers have used this data to bolster benchmarking presentations and evidence-based acquisition proposals. Simply visit www.pppmag.com/slides and click on the cover page for the State of Pharmacy Compounding 2017 issue to download the slide kit. You are welcome to use the slides in presentations both internally and externally; we simply ask that you retain the credit found on the bottom left corner of each slide.
We love hearing about improvements to pharmacy operations, so please send me a note at RMH@ridgewoodmedia.com if you have benefited from this data. Hearing your success stories will help us continue to expand and hone our practices to best serve your needs.
All the best,
R. Mitchell Halvorsen
As we do every year, we invite you to take advantage of our Compounding Slide Kit. Pharmacy Purchasing & Products is happy to provide much of the data you find on the following pages as PowerPoint slides. You are welcome to use this data in your own presentations; we hope it serves as a valuable support as you make the case for additional investments at your facility. And you are certainly welcome to incorporate the data into presentations you may make externally to educate your colleagues on compounding opportunities they may be considering. Simply access the slides on our website (www.pppmag.com/slides).
Perform an Assessment of Risk to Comply with USP <800>
Drive Compliance with the 340B Program
Managing Oral Chemotherapy
Comparison of USP <800> Gap Analysis Tools
March 2017 : IV Safety
Insourcing IV Compounding with Robotics
- In The Loop!
- Digital Edition
- Special Announcements